Skip to main content

Table 2 Association between CDK-based risk groups and clinicopathological parameters

From: Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

  CDK1SA (cut-off = 12.6) CDK2SA (cut-off = 222)
  Low High Significance (Chi-square) Low High Significance (Chi-square)
Sex Male 57 49   76 30  
Female 35 30 p =0.8817 55 10 p =0.0800
Age < 70 years 43 40   66 17  
≥ 70 years 49 39 p =0.7230 65 23 p =0.4888
Tumor size ≤ 3 cm 55 40   76 19  
> 3 cm 37 39 p =0.2955 55 21 p =0.3223
pN - 85 65   118 32  
+ 7 14 p =0.0759 13 8 p =0.1544
Stage IA 53 36   73 16  
IB 25 20   37 8  
IIA 12 19   18 13  
IIB 2 4 p =0.1652 3 3 p =0.0267
Histology Adenocarcinoma 64 54   101 17  
SCC 28 25 p =0.9961 30 23 p <0.0001
Facility Tohoku Univ 53 37   72 18  
Hyogo CC 39 42 p =0.2102 59 22 p =0.3557
\